SORIN DRAGHICI
Pilots at Brookville Rd, Plymouth, MI

License number
Michigan A5250918
Issued Date
Jun 2015
Expiration Date
Jun 2017
Category
Airmen
Type
Authorized Aircraft Instructor
Address
Address
8703 Brookville Rd, Plymouth, MI 48170

Professional information

Sorin Draghici Photo 1

Neoepitope Detection Of Disease Using Protein Arrays

US Patent:
8614169, Dec 24, 2013
Filed:
Feb 17, 2006
Appl. No.:
11/816471
Inventors:
Michael Tainsky - Southfield MI, US
Sorin Draghici - Plymouth MI, US
Madhumita Chatterjee - Lake Orion MI, US
Assignee:
Wayne State University - Detroit MI
International Classification:
C40B 30/04
US Classification:
506 9
Abstract:
A biosensor for use in detecting the presence of diseases, the biosensor comprising a detector for detecting a presence of at least one marker indicative of a specific disease. A method of determining efficacy of a pharmaceutical for treating a disease or staging disease by administering a pharmaceutical to a sample containing markers for a disease, detecting the amount of at least one marker of the disease in the sample, and analyzing the amount of the marker in the sample, whereby the amount of marker correlates to pharmaceutical efficacy or disease stage. Markers for gynecological disease selected from the list in Table 8. An immuno-imaging agent comprising labeled antibodies, whereby the labeled antibodies are isolated and reactive to proteins overexpressed in vivo. Informatics software for analyzing the arrays of claim 17, the software including analyzing means for analyzing the arrays.


Sorin Draghici Photo 2

Neoepitope Detection Of Disease Using Protein Arrays

US Patent:
2013012, May 16, 2013
Filed:
Jul 25, 2011
Appl. No.:
13/811687
Inventors:
Michael Tainsky - Southfield MI, US
Sorin Draghici - Plymouth MI, US
Madhumita Chatterjee - Lake Orion MI, US
Assignee:
Wayne State University - Detroit MI
International Classification:
G01N 33/574
US Classification:
4241841, 506 9, 506 18, 506 39, 5303913
Abstract:
A biosensor for use in detecting the presence of diseases, the biosensor comprising a detector for detecting a presence of at least one marker indicative of a specific disease. A method of determining efficacy of a pharmaceutical for treating a disease or staging disease by administering a pharmaceutical to a sample containing markers for a disease, detecting the amount of at least one marker of the disease in the sample, and analyzing the amount of the marker in the sample, whereby the amount of marker correlates to pharmaceutical efficacy or disease stage. Markers for gynecological disease. An immuno-imaging agent comprising labeled antibodies, whereby the labeled antibodies are isolated and reactive to proteins overexpressed in vivo. Informatics software for analyzing the arrays, the software including analyzing means for analyzing the arrays.